Safe But Not Wholesome: The Troubling State of Trans Fat Regulation by Williams, Ross
Journal of Food Law & Policy 
Volume 3 Number 1 Article 4 
2007 
Safe But Not Wholesome: The Troubling State of Trans Fat 
Regulation 
Ross Williams 
University of Texas 
Follow this and additional works at: https://scholarworks.uark.edu/jflp 
 Part of the Agency Commons, Consumer Protection Law Commons, Food and Drug Law Commons, 
Food Studies Commons, Law and Society Commons, Public Policy Commons, and the Torts Commons 
Recommended Citation 
Williams, R. (2021). Safe But Not Wholesome: The Troubling State of Trans Fat Regulation. Journal of 
Food Law & Policy, 3(1). Retrieved from https://scholarworks.uark.edu/jflp/vol3/iss1/4 
This Article is brought to you for free and open access by ScholarWorks@UARK. It has been accepted for inclusion 
in Journal of Food Law & Policy by an authorized editor of ScholarWorks@UARK. For more information, please 
contact ccmiddle@uark.edu. 
SAFE BUT NOT WHOLESOME: THE TROUBLING
STATE OF TRANS FAT REGULATION
Ross Williams*
I. PREFACE: THE STARBUCKS PROBLEM .................................. 40
II. INTRODUCTION ....................................................................... 43
III. BACKGROUND ......................................................................... 46
A. Natural Sources of Trans Fat: Partially Covered by the FDA
R egulations ....................................................................... 46
B. The Risks and Benefits of Natural Trans Fats .................... 47
C. Artificial Trans Fats: Sources and Creation Through
Hydrogenation .................................................................. 48
D. Introduction of Artificial Trans Fats into the Food Supply ..... 49
E. Widespread Use, Warning Signs, and Enactment of the Current
R egulation ......................................................................... 49
F. Artificial Trans Fat's Negative Health Effects ..................... 50
IV. CURRENT REGULATION OF TRANS FATS ............................... 51
A. The Current Federal Regulations: Overbroad in Scope but
Under-Regulatory .............................................................. 53
1. H istory ....................................................................... 53
2. The Coverage of the Current Regulation ............... 56
3. Analysis of the Current Regulation .......................... 56
a. The FDA's definition of "trans fatty acid" is too broad. 57
b. The "less than 0.5 grams" labeling standard ............ 59
i. The standard allows continued use of PHVO
at relatively high levels .................................. 60
ii. The standard is mandatory, leaving consumers
in the dark ..................................................... 61
iii. The current standard distorts the wholesomeness
of high saturated fat foods ........................... 62
c. The current regulations do not address restaurants
and other food vendors ........................................... 63
B. Local Efforts to Limit the Amount of Trans Fat in the
Food Supply ....................................................................... 63
V. THE CSPI PETITION ............................................................... 65
A. CSPIs Requests ................................................................. 66
JOURNAL OF FOOD LAW & POLICY
B. Analysis of CSPI's Requests ............................................... 67
1. A Narrowed Scope Allows CSPI's Tolerance Proposal
to Swallow its Requests for GRAS Removal,
"Safe Condition" Revocation, and Prior
Use Prohibition .......................................................... 67
2. The Effective Denial of CSPI's Requests
for Announcement and Education ........................... 71
3. CSPI's Prediction of State, Local, and Private Action 71
VI. RECOMMENDATIONS FOR FUTURE ACTION BY THE FDA .......... 73
VII. CONCLUSION ......................................................................... 79
I. PREFACE: THE STARBUCKS PROBLEM
On March 7, 2007, the New York Times reported that Starbucks,
the retail coffee chain which sells millions of baked goods every day
from its over 8,700 U.S. stores, had asked its suppliers to eliminate
all trans fats from their products by the end of the year.' The big
story for New York readers, though, was not that Starbucks was re-
quiring the elimination of trans fats from its baked goods. In fact,
New York City had just passed an ordinance strictly limiting the use
of artificial trans fats, the type present in partially hydrogenated
vegetable oil (PHVO), by virtually all of the city's food service estab-
lishments.2 Rather, the "scoop" for New York readers was the
source of the trans fats being eliminated by Starbucks' bakeries-
butter!.
The article reported that U.S. wholesale bakeries were being
forced to take butter out of their recipes because it contains small
amounts of natural trans fats (the type present in products devel-
oped from the fat of ruminants), even though a large body of evi-
dence suggests that those fats may actually be beneficial to health."
* Ross Williams will receive his J.D. from the University of Texas School of
Law in May of 2008. He would like to thank Professor Thomas McGarity for all of
his help and encouragement in preparing this article.
1. Kim Severson, Trans Fat Fight Claims Butter as a Victim, N.Y. TIMES, Mar. 7,
2007, at Fl.
2. New York City Health Code § 81.08 (effective July 1, 2007); see also New
York, N.Y., Dep't of Health & Mental Hygiene, Board of Health-Notice of Adoption of an
Amendment (§ 81.08) to Article 81 of the New York City Health Code, available at
http://www.nyc.gov/html/doh/downloads/pdf/public/notice-adoption-hc-art8l-
08.pdf.
3. See Severson, supra note 1.
4. See Janet Raloff, Trans Fats are Bad, aren't they? (Dec. 16, 2006),
http://www.sciencenews.org/articles/20061216/food.asp (last visited Dec. 28,
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Apparently, Starbucks' request was causing great confusion in the
food industry. Matthew Reich, a supplier of baked goods to 500
Starbucks locations from Philadelphia to Hartford, complained that
the request was "causing problems for every big baker in the coun-
try," and that he personally "didn't even know where to find trans-
free margarine."5 Because of the short notice, many bakeries were
reacting by hastily replacing butter with palm oil,' margarine, and
other processed substances high in saturated fat-a type of fat gen-
erally known to have a significant negative effect on heart health.'
Starbucks company spokesman Brandon Borman was quoted as
saying that "for [Starbucks], it's easier for the customer to walk in
and see zero grams trans fat rather than zero grams artificially cre-
ated trans fat."' The New York Times article explained that while the
New York City ordinance only covers artificial trans fats, the Food
2007) (discussing the potential health benefits of the non-regulated trans fat, li-
noleic acid (CIA), which occurs and is de facto eliminated from recipes with the
regulated natural trans fat, vaccenic acid); Janet Raloff, The Good Trans Fat:Will One
Family of Animal Fats Become a Medicine?, 159 (9) Sc. NEWS 136 (2001); Food Label-
ing: Trans Fatty Acids in Nutrition Labeling, Nutrient Content Claims, and Health
Claims, 68 Fed. Reg. 41433, 41461 (July 11, 2003) (codified at 21 C.F.R. pt. 101)
(acknowledging that vaccenic acid metabolizes onto CIA in the human body);
FOOD & NUTRITION BD., INST. OF MED. OF THE NAT'L ACADS. (IOM), DIETARY
REFERENCE INTAKES FOR TRANS FATTY ACIDS (2002), at 14,
http://www.iom.edu/Object.File/Master/13/083/TransFattyAcids.pdf (last visited
Dec. 28, 2007) [hereinafter DIETARY REFERENCE INTAKES] (suggesting that eliminat-
ing all trans fat, including that from ruminant sources, might introduce undesirable
effects, such as inadequate intake of protein and micronutrients); S. Banni et al.,
Vaccenic Acid Feeding Increases Tissue Levels of Linoleic Acid and Suppresses Develop-
ment of Premalignant Lesions in Rat Mammary Gland, 41(1-2) NUTR. CANCER 91, 91-97
(2001); E. Thom et al., Conjugated Linoleic Acid Reduces Body Fat in Healthy Exercising
Humans, 29(5) J. INT'L MED. RES. 392, 392-96 (2001); H. Blankson et al., Conjugated
Linoleic Acid Reduces Body Fat Mass in Overweight and Obese Humans, 130(12)J. NUTRI-
TION 2,943, 2,943-48 (2000); Letter from Gregory D. Miller, Senior Vice Pres. of
Nutrition & Prod. Innovation, Nat'l Dairy Council, & PeterJ. Huth, Dir. of Reg. &
Res. Transfer, Nat'l Dairy Council, to Div. of Dkts. Mgt., Food & Drug Admin. (June
18, 2004) (on file with author); D. Mozzafarian et al., Trans Fatty Acids and Cardio-
vascular Disease, 354 (15) NEW ENG.J. MED. 1,601, 1,601-13 (2006) (stating that "the
sum of the current evidence suggests that the public health implications of consum-
ing trans fats from ruminant products are relatively limited" but warning that that
this may be the result of relatively low consumption of trans fats from animal
sources compared to artificial ones).
5. Severson, supra note 1.
6. See id.
7. See WORLD HEALTH ORG. (WHO), DIET, NUTRITION AND THE PREVENTION OF
CHRONIC DISEASES, WHO TECHNICAL REPORT SERIES 916, at 82 (Geneva 2003),
available at http://www.who.int/dietphysicalactivity/publications/trs9l6/en/.
8. Severson, supra note 1.
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and Drug Administration (FDA) labeling regulation recognizes no
difference between artificial and natural trans fats and covers them
both. Aside from illustrating a general lack of awareness as to the
FDA regulation's coverage,9 this reaction demonstrates the way in
which large producers like Starbucks treat the FDA regulation, and
illustrates the local efforts to regulate trans fats as a de facto ban on
trans fat generally, removing potentially beneficial natural trans fats
from food and hastily replacing them with substances known to be
more harmful to heart health simply because the natural trans fat
sources are covered by the federal, and potentially some local, regu-
lations.
The New York Times article also provides a quote that is symp-
tomatic of the wider public misunderstanding regarding trans fat
regulation: Marion Nestle, nutrition professor at New York Univer-
sity and author of Safe Food: Bacteria, Biotechnology, and Bioterrorism,
said that "this is an important issue because anything made with
animal fats will have trans fats and make it impossible to claim trans
fat-free. Milk has trans fats, after all, and you can see what a mess
this is going to cause."'" This statement is inaccurate for several rea-
,ns: there is no definition of "trans fat free" in the current FDA
regulations;" at the current serving size, whole milk and whipped
butter are both allowed to claim that they contain zero grams of
trans fat per serving;' and products made with animal fats can still
claim that they contain zero grams trans fat on their nutrition label
as long as the individual serving size of the products contains less
than 0.5 grams of the regulated type of natural trans fat per serv-
ing. 1
Ultimately, the article raises two key issues: the widespread
misunderstanding regarding trans fat regulation, and the way in
which the current federal regulation" interacts with a myriad of re-
cently passed local ordinances" to influence Starbucks and other
9. The FDA regulation actually covers only nonconugated trans fatty acids, one
type of trans fat present in animal fats. See 68 Fed. Reg. at 41461.
10. Severson, supra note 1.
11. Indeed, the sections referring to it were intentionally removed by the draft-
ers. See 68 Fed. Reg. at 41434.
12. 21 C.F.R. § 101.9(c)(2)(ii) (2006).
13. Id.; see also 21 C.F.R. § 101.12 (2006).
14. 21 C.F.R. § 101.9(c)(2)(ii) (2006).
15. See New York City Health Code (N.Y.) § 81.08 (2006). See also Nat'l Rest.
Ass'n, Trans Fat Legislation, http://www.restaurant.org/government/state/
nutrition/billstransfat.cfm (last visited Dec. 28, 2007) (listing current efforts by
states to regulate trans fats).
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national food producers and suppliers to remove both artificial and
natural trans fats in favor of processed oils high in saturated fats,
which may result in a negative net effect on public health. 6 The
latter issue may also be affected by businesses' overreaction to po-
tential tort suits regarding the continued use of trans fats.17 This
article explores these issues and others regarding the current state
of trans fat regulation and suggests possible avenues for change.
II. INTRODUCTION
Thanks to advances in technology, the American food system
has grown from an amalgamation of discrete, local supply chains
into a system organized on a regional, national, and global scale.'"
While our food system has become increasingly complex, the
sources that supply it have decreased significantly in number: more
and more Americans are being fed by fewer and fewer food facili-
ties.'" Food safety regulation has evolved along with our food sys-
tem. The development of a national market for food and the desire
for uniform regulations to combat unsanitary conditions engen-
dered the early twentieth century movement away from a predomi-
nant reliance on state and local regulation of food safety and toward
16. A negative net effect on public health may result from the harmfulness of
saturated fat on heart health in conjunction with the potential detriments of remov-
ing natural trans fat sources. See DIETARY REFERENCE INTAKES, supra note 4, at 14;
Banni et al., supra note 4, at 392-96; Blankson et al., supra note 4, at 2,943-48;
Miller, supra note 4; Mozzafarian et al., supra note 4, at 1,601-13.
17. Given the new scientific evidence and public and industry awareness of the
dangers of trans fats, food producers and restaurants may be overreacting in ways
similar to Starbucks out of recognition that reliance on rulings similar to those that
insulated them from previous tort suits may be misplaced if the producers and
restaurants continue to use trans fats in their foods. See Ctr. for Sci. in the Pub.
Interest (CSPI), Petition for Rulemaking to Revoke the Authority for Industry to use Par-
tially Hydrogenated Vegetable Oil in Food at 30-31 (filed May 18, 2004), available at
http://cspinet.org/new/pdf/trans-fat.petition-final-may-18.pdf (arguing that in
the future, private parties may sue restaurants or food companies for continuing to
use partially hydrogenated vegetable oils when healthier alternatives exist; citing for
comparison Pelman v. McDonald's, 237 F. Supp. 2d 521, 532 (S.D.N.Y. 2003) (hold-
ing that complaint would state a tort claim "if McDonald's products are so extraor-
dinarily unhealthy that they are outside the reasonable contemplation of the con-
suming public or that the products are so extraordinarily unhealthy as to be dan-
gerous in their intended use), and BanTransFats.com v. Kraft Foods N. Am., Inc., CV
032041 (Martin County Super. Ct. Cal. May 2003)).
18. COMM. TO ENSURE SAFE FOOD FROM PROD. TO CONSUMPTION, IOM, ENSURING
SAFE FOOD FROM PRODUCTION TO CONSUMPTION 17-18 (Nat'l Acad. Press 1998).
19. Id. at 19.
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the gradual creation of the large federal regulatory bureaucracy of
today."° As much as the public relies on that bureaucracy to ensure
the safety of the food supply, the increasingly oligarchical food in-
dustry has come to rely on federal regulations as well because of the
uniformity and relative predictability that they provide to the huge
operations that supply food to the national market.
The resulting system is a fragile one; a single major incident can
easily have national effects.' The widespread public recognition
that trans fats are deleterious to health, which followed implementa-
tion of the Food and Drug Administration (FDA) regulation requir-
ing the listing of trans fat content on food labels, is an example of
just such an incident: a nearly omni-present ingredient in our food,
partially hydrogenated vegetable oil, was making us sick. Labels and
ingredient lists on food packages in grocery stores across the nation
seemed to change overnight. Growing public concern over the
presence of trans fats and the absence of a federal regulation requir-
ing producers to limit or eliminate trans fats from our food supply
led state and local governments to pass regulations to fill the regula-
tory gap.'
As a result of such efforts, food producers from the largest cor-
porations to the smallest street vendors in some localities were effec-
tively forced to change one of the bedrock principles of their food
preparation procedures: the fat they cook with. Today, the busi-
nesses that supply our national food system, including the bakeries
that supply Starbucks, face both a federal regulation defining trans
fats in a potentially overbroad way and a patchwork of local regula-
tions limiting the presence of trans fats in the food supply, rather
than a single preemptive federal standard limiting the presence of
trans fat in our food in a uniform manner. To comply efficiently
with the numerous local regulations, to respond effectively to public
hysteria, and potentially out of concern for the tort consequences of
continued trans fat use," many food producers are making rapid
changes based on the FDA's definition of trans fats, changes that
might result in an overall negative effect on public health.'"
20. Id. at 21-22.
21. Id. at 19.
22. See Janet Frankston Lorin, Associated Press, Legislating food becoming issue du
jour in state, city government, Feb. 18, 2007, available at http://
www.boston.com/news/local/connecticut/articles/2007/02/17/legislating__food-b
ecoming-issueduour instatecitygovernment/.
23. See CSPI, supra note 17.
24. See DIETARY REFERENCE INTAKES, supra note 4; see also WHO, supra note 7.
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This article explores the history, current regulations, ongoing
debate, and potential future regulations concerning trans fat in
foods, ultimately recommending that the FDA remove the "gener-
ally recognized as safe" (GRAS) status of artificial trans fat sources,
limit or eliminate their presence in our national food supply
through appropriate preemptive regulations, amend its definition of
trans fatty acid pending the completion of further research to de-
termine whether natural trans fats pose risks similar to artificial va-
rieties, and sponsor industry and consumer education on this sub-
ject, among other things. These steps would protect public health
and insure the uniformity and predictability that the food industry
needs to provide safe and wholesome foods on a national level. Ad-
ditionally, this article analyzes the legal and policy issues that such
action, or continued inaction, would raise.
. This article begins with a brief description of the science and
history behind the use of trans fatty acids: the types of trans fats
and their sources, the movement that led to the nearly universal
adoption of artificial trans fat-containing substances for use in cook-
ing, the subsequent backlash against their use, and the scientific evi-
dence supporting the idea that artificial trans fats are dangerous.25 I
then turn to a discussion of the history, pros and cons, and current
state of the federal government's regulation of trans fats, followed
by an analysis of the current grassroots movement to regulate trans
fats at the state and local government levels in the face of the federal
government's inactivity. 6
Next, this article analyzes the FDA citizen action "Petition for
Rulemaking to Revoke the Authority for Industry to use Partially
Hydrogenated Vegetable Oils in Foods" filed by the Center for Sci-
ence in the Public Interest (CSPI) in depth, supplemented by CSPI
Executive Director Michael Jacobson's thoughts on the current state
of trans fat regulation and the FDA's involvement therein.' Finally,
I discuss whether the FDA must, or at least should, grant the CSPI
petition or a similar alternative, additional steps that the FDA
should take, the issues of federalism that such a regulation would
implicate, whether any resulting regulation should be preemptive,
and the potential consequences of passage on the area of tort litiga-
tion."
25. See infra notes 29-72 and accompanying text.
26. See infra notes 73-139 and accompanying text.
27. See infra notes 140-178 and accompanying text.
28. See infra notes 179-207 and accompanying text.
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III. BACKGROUND
To understand the regulations regarding trans fats, it is first
necessary to have some basic understanding of what trans fats are.
The following section provides a brief overview of the different
types of trans fats; their origins, characteristics, and effects on hu-
man health; and also explains their relation to the current regula-
tions.
A. Natural Sources of Trans Fat:
Partially Covered by the FDA Regulations
Humans have consumed trans fats for as long as they have
eaten ruminants. Indeed, many people do so at birth, as trans fats
are found in the breast milk of mothers in amounts proportional to
their dietary intake.' The 2-5% of total fat in ruminants that is
technically trans fat3° can be subdivided into two categories: conju-
gated linoleic acid (CLA)3' and non-conjugated linoleic acid in the
form of vaccenic acid.
This is an important distinction, because the Food and Drug
Administration (FDA) regulatory definition of trans fats covers only
non-conjugated trans fats." Thus, while the content per serving of
non-conjugated trans fats derived from ruminant sources must be
given on a product's nutrition label if the product contains 0.5
grams or more per serving, the amount of conjugated trans fat (CLA)
in the same food product is not regulated and need not be reported
on the nutrition label, regardless of the product's CLA content per
serving.' Because these two types of fat occur together in products
derived from ruminant fats, businesses like Starbucks that eliminate
trans fats altogether in an effort to attain broad compliance with
potential local ordinances limiting the use of trans fats end up
eliminating CLA de facto, even though it is not included in the trans
29. Sheila M. Innis & D. Janette King, Trans Fatty Acids in Human Milk are In-
versely Associated with Concentrations of Essential All-cis n-6 and n-3 Fatty Acids and
Determine Trans, but not n-6 and n-3, Fatty Acids in Plasma Lipids of Breastfed Infants,
70(3) AM.J. CLINICAL NUTRITION 383 (1999).
30. TRANs FAT TASK FORCE OF HEALTH CANADA, TRANSFORMING THE FOOD
SUPPLY (June 2006), at 4, available at http://www.hc-sc.gc.ca/fn-an/nutrition/gras-
trans-fats/tf-ge/tf-gtjrep-rape.html.
31. T.R. Dhiman et al., Linoleic Acid (CLA) Content of Milk from Cows Offered Diets
Rich in Linoleic and Linolenic Acid, 83(5)J. DAIRY SCI. 1,016 (2000).
32. 68 Fed. Reg. at 41461.
33. Id.
34. 21 C.F.R. § 101.9(c)(2)(ii) (2006).
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fatty acid content listed on nutrition labels and may actually be
beneficial to human health.'
B. The Risks and Benefits of Natural Tram Fats
Scientific evidence suggests that natural trans fats may not have
the same negative health effects that are associated with artificial
trans fats.' Indeed, CLA in particular may be beneficial to human
health.37 Studies have shown that CLA may reduce body fat in both
healthy and overweight humans" and may also prevent breast 9 and
colorectal cancer."° Additionally, vaccenic acid (the non-conjugated
trans fat contained in ruminant meat and covered by the FDA regu-
lations) is actually converted to CIA when it reacts with chemicals in
the body during digestion,4 and some research suggests that vacce-
nic acid intake may reduce the risk of breast cancer."
Some scientific evidence, however, suggests that trans fats from
ruminant sources might also have negative effects. One study sug-
gests that CIA may have negative effects on cardiovascular health
and insulin resistance in obese men,3 and a 2006 review of the lit-
erature on natural trans fat sources in the New England Journal of
35. See Banni et al., supra note 4; Thorn et al., supra note 4; Blankson et al., supra
note 4; Miller, supra note 4; Mozzafarian et al., supra note 4.
36. See Miller, supra note 4; see also Mozzafarian et al., supra note 4.
37. See Thorn et al., supra note 4; see also Blankson et al., supra note 4.
38. See id.
39. See M.M. Ip et al., Prevention of Mammary Cancer with Linoleic Acid: Role of the
Stroma and the Epithelium, 8(1) J. MAMMARY GLAND BIOLOGY & NEOPLASIA 103, 103-
18 (2003) (stating that, taken together, the current data suggest that CIA may be an
excellent candidate for the prevention of breast cancer); but see L.E. Voorrips et al.,
Intake of Linoleic Acid, Fat, and other Fatty Acids in Relation to Postmenopausal Breast
Cancer: the Netherlands Cohort Study on Diet and Cancer, 76(4) AM. J. CLINICAL NUrRI-
TION 873, 873-82 (2002) (stating that the suggested anticarcinogenic property of
CLA in animal and tissue studies was not confirmed in humans through review of
data from a cohort study conducted in the Netherlands).
40. Susanna C. Larsson et al., High-fat Dairy Food and Linoleic Acid Intakes in
Relation to Colorectal Cancer Incidence in the Swedish Mammography Cohort, 82(4) AMER.
J. CLINICAL NUTRITION 894, 894-900 (2005) (concluding that prospective data sug-
gests that high intakes of high-fat dairy foods and CLA might reduce the risk of
colorectal cancer).
41. 68 Fed. Reg. at 41461; see also Banni et al., supra note 4.
42. See Banni et al., supra note 4.
43. See Ulf Risrus et al., Supplementation With Linoleic Acid Causes Isomer-
Dependent Oxidative Stress and Elevated C-Reactive Protein, 106 CIRCULATION 1,925
(2002).
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Medicine noted that their limited negative effect on public health
might be due to their low occurrence in the diet."
Despite the evidence on both sides regarding the benefits and
risks of natural trans fat consumption, these fats may provide impor-
tant indirect benefits to public health as well: the Institute of Medi-
cine (1OM) has acknowledged that any potential benefits of remov-
ing natural trans fat from the diet, including that from ruminant
sources, might introduce undesirable effects, such as inadequate
intake of protein and micronutrients.' Consequently, even though
natural trans fat sources may have some negative public health ef-
fects, their elimination from the food supply might result in a nega-
tive net effect on public health by removing the indirect benefits
that they provide. While the FDA includes natural trans fat sources
in its labeling regulation regardless of this information, some local
U.S. governments have chosen to exclude natural trans fat sources
from their regulations while awaiting further study.'
C. Artificial Trans Fats: Sources and Creation Through Hydrogenation
Hydrogenation is the process whereby hydrogen atoms are
added to a molecule through a chemical process involving a catalyst
and pressure.47 A fat molecule can only carry a certain number of
hydrogen atoms, and once it carries the maximum number it is re-
ferred to as a saturated fat because it is saturated with hydrogen. 8
Thus, partially hydrogenated oils contain unsaturated fats and are
very low in saturated fats.
Partially hydrogenated vegetable oils (PHVO) are the main
source of artificial trans fats and dietary trans fats generally. 9 Until
recently, PHVO was a basic building block of many food products,
either as oil for frying, as shortening for baked goods, or as marga-
rine for spreads." Whereas natural trans fats occur in animal fat at a
level of 2-5% of total fat, artificial trans fats occur in PHVO products
as up to 45% of total fat content.5
44. Mozzafarian et al., supra note 4, at 1,609.
45. DIETARY REFERENCE INTAKES, supra note 4, at 14.
46. See New York, N.Y., Dep't of Health & Mental Hygiene, supra note 2.
47. RAYMOND CHANG, ESSENTIAL CHEMISTRY 375 (McGraw Hill 1996).
48. MARY K. CAMPBELL, BIOCHEMISTRY 198-99 (3d ed. Saunders C. Publishing
1999).
49. New York, N.Y., Dep't of Health & Mental Hygiene, supra note 2.
50. Id.
51. TRANS FAT TASK FORCE OF HEALTH CANADA, supra note 30.
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D. Introduction of Artificial Trans Fats into the Food Supply
The process for hydrogenating liquid oils was brought to Amer-
ica when Proctor and Gamble acquired the U.S. patent and began
marketing the first Crisco in 1911." By the 1960s, PHVO had re-
placed animal fat as the most commonly used fat in the U.S., and
health advocates began to argue that the unsaturated fats that they
contained were healthier than saturated fats. Food producers like
PHVO because it can be used as a malleable fat, is solid at room
temperature, melts when baked or consumed, is very low in satu-
rated fat, is cheap, and increases shelf life. 3
Despite PHVO's widespread popularity among food producers,
fast food restaurants continued to use beef fats and tropical oils
high in saturated fats.' But in 1984, the Center for Science in the
Public Interest (CSPI) and other consumer groups began a six-year
campaign to end the use of those oils in fast food." By 1990, most
of the fast food industry had switched from oils high in saturated
fats to PHVO.6
E. Widespread Use, Warning Signs, and Enactment
of the Current Regulation
By 1987, comments in CSPI's Nutrition Action newsletter
showed just how integral PHVO had become in our food supply.
7
In the newsletter, CSPI acknowledged that PHVO played a vital role
in the nation's food supply, but reassured its readers that PHVO is
not harmful to human health, is relatively benign, and is not a cause
of heart disease. 8 In fact, CSPI claimed that food producers were
actually "(i)mproving on (n)ature" through hydrogenation and ulti-
mately averred that the safety of PHVO was "cause for thanks, be-
cause these fats are everywhere."" In 1988, the first scientific evi-
dence that the trans fats contained in PHVO could have harmful
52. Crisco, History/Timeline, http://www.crisco.com/about/history/1911.asp
(last visited Dec. 28, 2007).
53. See TRANS FAT TASK FORCE OF HEALTH CANADA, supra note 30, at 12.
54. Mary G. Enig, The Tragic Legacy of Center for Science in the Public Interest (CSPI)






59. See Enig, supra note 54.
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effects began to emerge, but the advocates who had pushed for the
switch away from saturated fats and toward PHVO defended the
healthfulness of trans fats up until 1994, when scientists estimated
that approximately 30,000 American deaths from heart disease an-
nually were attributable to trans fat consumption.' Shortly thereaf-
ter, CSPI called a news conference to condemn the use of PHVO
and filed its first FDA citizen action petition regarding trans fats on
February 14, 1994, requesting that the FDA require mandatory la-
beling of trans fatty acid content in foods." The petition resulted in
action in 2003 that culminated in the labeling rule implemented in
2006, nearly twelve years after the initial petition was filed.
F. Artificial Trans Fat's Negative Health Effects
While some critics continue to doubt even the most convincing
evidence that artificial trans fats have a negative effect on health,
these fats are now generally recognized as harmful to cardiovascular
health in particular.' Moreover, a mounting body of evidence sug-
gests that they may have a deleterious effect on health in other ways
as well.
A 2006 article published in the New England Journal of Medicine
reviewed the scientific evidence and concluded that there is strong
proof that a connection exists between trans fat consumption and
an increased risk of coronary heart disease (CHD)6 Specifically, the
scientific evidence shows that trans fat is markedly more harmful to
cardiovascular health than saturated fats when the two substances
are consumed in similar amounts, and that replacement of trans fats
60. W.C. Willett & A. Ascherio, Commentary: Trans fatty acids: are the effects only
marginal?, 84 AM.J. PUB. HEALTH 722 (1994).
61. Letter fromJohn M. Taylor, III, Assoc. Commr. for Reg. Affairs, FDA, to Dr.
Michael F. Jacobson, Exec. Dir., Ctr. Sci. Pub. Interest, Re: Docket No. 94P-0036
(Dec. 19, 2003).
62. 21 C.F.R. § 101.9(c)(2)(ii) (2006).
63. See Steven Milloy, Trans Fat Hysteria could be Lawsuit Bonanza (Nov. 9, 2006),
http://www.foxnews.com/story/0,2933,228537,00.html (last visited Dec. 28, 2007);
see also Gary Becker, The Becker-Posner Blog, Comment on the New York Ban on
Trans Fat-Becker (Dec. 21, 2006), http://www.becker-posner-blog.com/
archives/2006/12/comment on the_4.html (last visited Dec. 28, 2007).
64. See Mozaffarian et al., supra note 4, at 1,613; see also TRANS FAT TASK FORCE
OF HEALTH CANADA, TRANSFORMING THE FOOD SUPPLY: APPENDIX 9iii,
CONSULTATION ON THE HEALTH IMPLICATIONS OF ALTERNATIVES TO TRANS FATTY
ACIDS, SUMMARY OF RESPONSES FROM EXPERTS (2006), available at http://www.hc-
sc.gc.ca/fn-an/nutrition/gras-trans-fats/tf-ge/tf-gt-app9iii-e.html.
65. See Mozaffarian et al., supra note 4, at 1,613.
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with non-trans unsaturated fats could cut a person's risk of CHD by
as much as 53%.' Additionally, trans fats have been shown to have a
sinister effect on cholesterol levels, a key indicator of heart health:
while trans fat consumption increases the level of LDL (bad) choles-
terol, it also decreases the level of HDL (good cholesterol), resulting
in a negative effect on cholesterol levels that is significantly larger
than that caused by saturated fat consumption.67
In addition, trans fats may be harmful to more than just heart
health. Though there is no scientific consensus, some studies have
suggested that trans fat consumption may also result in higher risks
of obesity,' type II diabetes, 9 infertility,"0 and even cancer.' Given
these and other findings, the IOM's recommendation that dietary
trans fats be as low as possible" seems warranted. The next section
discusses the current state of regulations concerning these sub-
stances.
IV. CURRENT REGULATION OF TRANS FATS
There are two basic sources of the current statutes concerning
trans fats: the federal government (via the Food and Drug Admini-
stration's (FDA) authority over food labeling), and state and local
governments. Rather than focusing on the effect that different
types of trans fats have in the human body, the FDA has chosen to
regulate a chemical structure, with the result that the amount of cer-
tain types of natural trans fats must be factored into a product's to-
66. See F.B. Hu et al., Dietary Fat Intake and the Risk of Coronary Heart Disease in
Women, 337(21) NEW ENG.J. MED. 1491 (1997).
67. See A. Ascherio et al., Trans Fatty Acids and Coronary Heart Disease, 340(25)
NEW ENG.J. MED. 1994 (1999).
68. See Anna Gosline, Why Fast Foods are Bad, even in Moderation (June 12, 2006),
http://www.newscientist.com/channel/health/dn9318-why-fast-foods-are-bad-even-
in-moderation.html (last visited Dec. 28, 2007); see also Six Years of Fastfood Supersizes
Monkeys, 2556 NEW SCIENTIST 21 (June 17, 2006), available at http://
www.newscientist.com/channel/health/mg19025565.000-six-years-of-fastfood-fats-
supersizes-monkeys.html.
69. See TRANS FAT TASK FORCE OF HEALTH CANADA, supra note 64; but see R.M.
van Dam et al., Dietary Fat and Meat Intake in Relation to Risk of Type 2 Diabetes in
Men, 25(3) DIABETES CARE 417, 422 (2002) (suggesting no such correlation when
confounding factors were factored into the analysis).
70. See Jorge Chavarro et al., Dietary Fatty Acid Intakes and the Risk of Ovulatory
Infertility, 85(1) AM.J. CLINICAL NUTRITION 231-37 (2007).
71. See Jorge Chavarro et al., A Prospective Study of Blood Trans Fatty Acid Levels
and Risk of Prostate Cancer, 47 PROC. AMER. ASSOC. CANCER RES. (2006); but see TRANS
FAT TASK FORCE OF HEALTH CANADA, supra note 64.
72. See DIETARY REFERENCE INTAKES, supra note 4, at 14.
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tal trans fat content, leading big companies like Starbucks to remove
them even though those fats may actually be beneficial to human
health.73 As the Starbucks story attests, these natural fats are often
hastily replaced with processed fats high in saturated fat but lacking
in the beneficial fats that the natural ingredients contain. Conse-
quently, the current regulatory situation may result in a negative net
effect on public health.74
Aside from the effect that the federal regulations have on large
producers, there is a second force effecting large food producers
and retailers in a similar way: the necessity of complying with mul-
tiple local ordinances, some of which might require the removal of
the natural trans fats covered by the FDA, may prompt national
businesses such as Starbucks to play it safe by going to the extreme
of eliminating all of the trans fats that the FDA labeling requirement
covers in hopes of achieving broad compliance. The sweeping
changes resulting from these two forces may have a negative effect
on the safety and wholesomeness of the food supply because they
are resulting in natural trans fats being eliminated (even though sci-
entific evidence suggests that such fats may be beneficial to con-
sumer health) by large producers and retailers such as Starbucks in
exchange for added saturated fats from the substituted palm oils,
margarines, and interesterified fats that are either known to be det-
rimental to heart health75 or are potentially deleterious." This sec-
tion will analyze each of these regulatory sources in turn-their his-
tory and coverage-to expose their individual shortcomings and the
problems created by their simultaneous operation.
73. See 68 Fed. Reg. at 41461.
74. See supra § III.B.
75. See WHO, supra note 7, at 88.
76. See Ben Harder, A Trans Fat Substitute Might Have Health Risks Too (Feb. 10,
2007), 171(6) SCIENCE NEWS ONLINE, http://www.sciencenews.org/articles/
20070210/food.asp (last visited Dec. 28, 2007) (citing K. Sundram et al., Stearic Acid
Rich Interesterified Fat and Trans-Rich Fat Raise the LDL/HDL ratio and Plasma Glucose
Relative to Palm Olein in Humans, 4 NuTRmON & METABOLISM 3 (2007), available at
http://www.nutritionandmetabolism.com/content/4/1/3). Michael Jacobson
points out that the study cited "had a 'bizarrely high' proportion of saturated fatty
acids," and states that "(i)t looks to me like the palm oil industry was looking for a
way to put a potential competitor in a bad light [by using] unrealistic conditions."
Id.
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A. The Current Federal Regulations: Overbroad
in Scope but Under-Regulatory
While the current FDA regulation requiring the listing of trans
fat content on the nutrition facts label of food products has indi-
rectly led producers to limit the amount of trans fat contained in
their products to an amount lower than 0.5 grams per serving (the
amount below which trans fat content can be claimed as "zero"),' it
is flawed for several reasons: the 0.5 grams per serving allowance is
too high; the definition of trans fats is too broad; and the regulation
merely requires the labeling of a food's trans fat content rather than
directly limiting the amount of trans fat that a given food product
may contain, leading local governments to pass a multitude of dif-
ferent regulations to fill in the regulatory gaps left by the FDA. This
section looks at the history and current state of the federal regula-
tion regarding trans fat and discusses its benefits and shortcomings.
1. History
The road that led to the current regulation of trans fat was a
long one. Following the revelation that approximately 30,000
deaths result from coronary heart disease (CHD) due to trans fat
consumption annually,78 the Center for Science in the Public Interest
(CSPI) changed its position on PHVO and filed a citizen action peti-
tion on February 14, 1994, urging the FDA to require that a prod-
uct's trans fat content be reported on its nutrition facts label. 9 A
proposed rule appeared in the Federal Register on November 17,
1999, suggesting that the nutrition labeling regulations be amended
to require that the amount of trans fats in a food be included in the
amount and percentage daily value declared for saturated fat with a
footnote indicating trans fat content per serving when it exceeded
0.5 grams.'
Three comment periods were successively opened for the pro-
posed rule.8' On September 18, 2001 (over seven years after the
initial citizen action petition was filed), the Office of Information
77. 21 C.F.R. § 101.9(c)(2)(ii) (2006).
78. See Willett & Ascherio, supra note 60.
79. Taylor, supra note 61.
80. Food Labeling: Trans Fatty Acids in Nutrition Labeling, Nutrient Content
Claims, and Health Claims, 64 Fed. Reg. 67246, at 62755-56 (Nov. 17, 1999) (codi-
fied as amended in 21 C.F.R. pt. 101). This proposed rule was dramatically
amended. See infta § IV.A.2.
81. 68 Fed. Reg. at 41436.
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and Regulatory Affairs of the Office of Management and Budget
sent a letter to the Secretary of Health and Human Services request-
ing that the FDA give greater priority to the November 1999 pro-
posed rule "in light of the growing body of scientific evidence sug-
gesting that consumption of trans fatty acids in foods increases the
consumer's risk of developing CHD." ' The letter went on to state
that such evidence strongly supported "the interests of the Govern-
ment to lower the incidence of and economic burden of CHD in the
United States" by limiting the presence of trans fats in the food sup-
ply.,
Following this letter, the FDA requested a report from the Insti-
tute of Medicine (IOM) on trans fats. In response to the FDA's re-
quest, the IOM issued a report in July of 2002.' In its report, the
IOM concluded that there is no known requirement for trans fatty
acids to facilitate specific body functions," and that because of the
increased risk of CHD that accompanies consumption of trans fats,
their Upper Tolerable Intake Level (UL) should be "zero."' How-
ever, the IOM also acknowledged the following:
Because trans fatty acids are unavoidable in ordinary diets, achieving [a
UL of zero] would require extraordinary changes in patterns of dietary
intakes. Such extraordinary adjustments may introduce other undesir-
able effects (e.g. elimination of foods, such as dairy products and meats,
that contain tram fatty acids may result in inadequate intakes of protein
and certain micronutrients) and unknown and unquantifiable health
risks may be introduced by any extreme adjustments in dietary pattern.
For these reasons, no UL is proposed. Nevertheless, it is recommended
that trans fatty acid consumption be as low as possible while consuming
a nutritionally adequate diet.87
Thus, while the IOM recommended, on the basis of evidence that
trans fatty acids (and particularly artificial trans fatty acids) are dele-
terious to health, that all trans fatty acid intake be zero, it acknowl-
edged that there may be indirect negative health effects resulting
from removing natural sources of trans fats from the diet that would
make complete elimination of all trans fatty acids from the diet ill-
82. Id.
83. Id.
84. DIETARY REFERENCE INTAKES, supra note 4.
85. Id. at 2.
86. Id. at 14.
87. Id.
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advised.' Following the first IOM report from July 2002, the FDA
published a final rule in the Federal Register onJuly 11, 2003.'
In a second report issued in December 2003 (shortly after the
FDA passed its current labeling regulation) at the request of Health
and Human Services, the Department of Agriculture, and Health
Canada, the IOM provided guiding principles for nutrition labeling
and fortification and stated "diets can be planned that provide less
than [one] percent of calories from [trans fatty acids] provided that
the only sources of [trans fatty acids] are naturally occurring (i.e., in
meats, poultry, and dairy products)."' Consequently, this second
report both reiterated the IOM's earlier observation that the elimi-
nation of natural trans fat sources from the diet would be ill-advised
and implied that the elimination of all artificial trans fat sources
would be feasible." In other words, the report implied that the op-
timum diet in terms of balancing trans fat content with overall
wholesomeness would be one that eliminated all artificial trans fat
sources while retaining natural trans fat sources for their overriding
nutritional benefits.'
"To minimize the need for multiple label changes and to pro-
vide additional time for compliance by small businesses," the FDA
set the effective date for the regulation as January 1, 2006-nearly
twelve years after CSPI filed its initial petition." By comparison, it
only took the FDA three years from the passage of the Nutrition
Labeling and Education Act of 1990 to issue and implement a final
rule setting standards for the listing of all of the other nutrients that
are provided on food labeling." If the 1994 estimates"5 were accu-
rate, approximately 360,000 Americans died from CHD attributable
to trans fat consumption in the time between the filing of CSPI's
initial petition and publication of the final rule. At the time that the
final rule was published, the FDA estimated the economic benefit to
88. See id.
89. 68 Fed. Reg. 41434.
90. FOOD & NUTRITION BD., IOM, DIETARY REFERENCE INTAKES: GUIDING





93. 68 Fed. Reg. at 41466.
94. Id at 41434.
95. See Willett & Ascherio, supra note 60.
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cost ratio of the labeling requirement would be sixty-five to one.'
While it is not clear exactly how much was spent on CHD attribut-
able to trans fat consumption in the time that it took the FDA to
approve the CSPI petition, the estimated mortality total and benefit
to cost ratio suggests that the economic cost of bureaucratic red
tape may have been daunting.
2. The Coverage of the Current Regulation
The current regulation97 was passed pursuant to the Nutrition
Labeling and Education Act of 1990's provisions allowing the Secre-
tary of Health and Human Services to add or delete nutrients in-
cluded in the food label through the regulatory power of the FDA,
provided that the Secretary or the FDA finds such action necessary
to assist consumers in maintaining healthy diet practices.98 It defines
trans fat as "all unsaturated fatty acids that contain one or more iso-
lated (i.e., nonconjugated) double bonds in a trans configuration,"
thereby including both artificial and (to a partial extent) natural
sources of trans fat." The regulation goes on to provide that where
a product contains less than 0.5 grams of trans fat per serving, no
trans fat content need be listed if the product makes no claims
about fat, fatty acid, or cholesterol content, and that if such claims
are made the product must include a value for trans fat content on
the nutrition label and must list that value as zero." Finally, if a
statement of a product's trans fat content is not required and not
listed, a footnote must be placed at the bottom of the label stating
"not a significant source of trans fat."' Consequently, the current
regulation requires labeling only within the parameters described
above: any elimination of trans fat is an indirect result and is volun-
tary as far as the FDA is concerned.
3. Analysis of the Current Regulation
As the Starbucks article attests, the current regulation has re-
sulted in several positive steps: many producers have reformulated
96. E-mail from Dr. Michael F. Jacobson, Exec. Dir., CSPI, to Ross Williams
(Mar. 11, 2007, 15:50:12 CST) (on file with author).
97. 21 C.F.R. § 101.9(c)(2)(ii) (2006).
98. 68 Fed. Reg. at 41434.
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their recipes to exclude artificial trans fats, and the level of general
public awareness of the dangers posed by trans fats has grown ap-
preciably since passage of the regulation. At first glance, this is per-
haps the best-case scenario for a regulation that seeks to limit the
inclusion of a harmful substance in food indirectly by requiring
producers to disclose the amount of the substance present in their
products. However, the regulation also has significant shortcomings
that may offset the benefits and that deserve comment and, ulti-
mately, amendment.
a. The FDA's definition of "trans fatty acid" is too broad
Perhaps the most important flaw in the current regulation, the
FDA's definition of trans fatty acid appears overbroad in that it cov-
ers natural sources of trans fats, leading to their elimination from
the recipes of many food producers and potentially to negative net
effects on health."2 Indeed, the soundness of both the FDA's regula-
tion of natural trans fat in general, and their regulation of non-
conjugated linoleic acid (but not conjugated linoleic acid (CLA)) in
particular, deserve closer scrutiny.
On one hand, while the FDA definition of trans fatty acids cov-
ers non-conjugated trans fats generally, it excludes the ruminant fat
CLA-a substance shown to have numerous health benefits.1 3 On
the other hand, the regulation covers the non-conjugated vaccenic
acid found simultaneously in the same animal fat deposits, even
though the FDA acknowledges that vaccenic acid is converted into
CLA in the body."M But because both vaccenic acid and CIA occur
together in animal fat, CLA is regulated de facto, even though it is
technically not covered under the FDA regulations. Consequently,
it would seem imprudent to include natural trans fats in the defini-
tion of trans fats that must be reported on nutrition labels, since
such labeling might mislead consumers into avoiding products con-
taining only natural trans fats (both CLA and vaccenic acid) that
might actually be beneficial to them in several different ways. °"
While some evidence suggests that natural trans fat consumption
might also have its risks, both the July 2002 IOM report published
prior to the issuance of the current FDA labeling regulation and the
December 2003 IOM report published shortly after issuance of the
102. See supra § III.B.
103. 68 Fed. Reg. at 41461.
104. Id,
105. Mozaffarian et al., supra note 4.
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regulation suggest that the elimination of natural trans fats from the
diet might not be advisable because of the indirect health benefits
that attend natural trans fat consumption.'" Indeed, some local U.S.
regulations seem to have followed the IOM's observations in those
reports by excluding natural trans fat sources from their trans fat
definitions.07
Moreover, the FDA's justification for this overbroad definition
seems to conflict with the purpose for passing the regulation in the
first place. The FDA's explanation for only requiring food produc-
ers to list some parts of a cow's fat on the nutrition label is that it is
regulating a chemical structure, rather than the functional or meta-
bolic aspects of the different types of trans fats.' 8 However, this
explanation seems to betray a short sighted approach by the FDA:
these regulations are, after all, being passed in response to recogni-
tion of the negative health effects of trans fat consumption, i.e. their
negative functional or metabolic effect in the human body. Given
that impetus, it may be unwise to define trans fats in a way that
might confuse the public as to the wholesomeness and safety of a
food product containing only natural trans fats. Consequently, it
seems that the way in which trans fatty acids are defined clashes with
the intent of the current regulation-"to provide information to as-
sist consumers in maintaining healthy dietary practices"' .- because it
might actually lead them to adopt less healthy practices by eliminat-
ing natural trans fats from their diets and substituting harmful proc-
essed oils high in saturated fats in their place.
In light of this apparent disconnect between the stated purpose
of the rule and the definition that drives it, an appropriate remedy
may involve changing the definition of "trans fats" to cover only arti-
ficial trans fat sources. This action would also help to divert the
wholesale removal of natural trans fat sources from the food supply,
though it is not clear that such action would be entirely effective
because, as the Starbucks article attests, the food industry has al-
ready begun the removal process in response to public concern.
Unfortunately, it appears that this problem could have been
prevented proactively had the FDA considered the potential nega-
tive effect of the broad scope of its trans fat definition in light of the
IOM's recommendations and amended the definition accordingly
106. See DIETARY REFERENCE INTAKES, supra note 4, at 14; see also GUIDING
PRINCIPLES, supra note 90.
107. See New York, N.Y., Dep't of Health & Mental Hygiene, supra note 2.
108. 68 Fed. Reg. at 41461.
109. Id at 41434.
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prior to approving the final rule. After the IOM suggested that any
consumption of trans fats increases the risk of CHD," ° the FDA
warned that it would "exercise its enforcement discretion" to pre-
vent manufacturers from either labeling their products with a trans
fat content prior to the passage of the final rule, or including the
proposed footnote stating that "intake of trans fats should be as low
as possible."' In other words, the FDA was threatening to punish
manufacturers if they attempted to inform consumers about their
product's content of a substance acknowledged by the IOM to be
harmful at any level of consumption on the rationale that such
forewarning might encourage consumers to eliminate all intake of
trans fatty acids, which the IOM had stated was not desirable."'
However, the FDA's inclusion of natural trans fats in its trans fat
definition has led manufacturers to eliminate natural trans fats in
response to public concern de facto. Thus, the FDA's threat of en-
forcement action exposed the fallacy of the definition of trans fatty
acids in the regulation-it includes natural sources of trans fats, lead-
ing the public and businesses such as Starbucks to call for their
elimination, even though the IOM has stated, and the FDA acknowl-
edges, that such elimination is undesirable. Because this elimination
is effectively happening now, it seems that the FDA should have
been more concerned with the over-breadth of its definition in light
of the IOM report, rather than with the possibility that food pro-
ducers would give consumers advance notice of harmful substances
in their food. By threatening to punish producers who sought to
eliminate all trans fats from their products, the FDA only delayed
the inevitable (and left the consumer uninformed longer), whereas a
change in the definition could have prevented the current problem
by addressing its root cause.
b. The "less than 0.5 grams" labeling standard
Another apparent shortcoming of the current regulation is its
allowance of a zero gram trans fat content listing on nutrition labels
when as much as 0.49 grams of trans fat is present in a food."' This
shortcoming raises several issues.
110. Hence its observation that the ideal UL for trans fats would be "zero."
DIETARY REFERENCE INTAKES, supra note 4, at 14.
111. 68 Fed. Reg. at 41434.
112. Id. at 41459.
113. 21 C.F.R. § 101.9(c)(2)(ii) (2006).
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i. The standard allows continued use of PHVO at relatively high
levels
One major problem with this standard is that it is high enough
to allow for significant continued use of PHVO. The trans fat to
total fat ratio of PHVO depends upon the method of hydrogenation
used.'4 Hydrogenation at twenty p.s.i., the former industry stan-
dard, results in PHVO that contains 40% of its total fat as trans fat."5
This is very high in comparison to natural sources, for instance,
wherein 2-5% of the total fat is composed of trans fat."6 Conse-
quently, PHVO produced through low pressure hydrogenation can-
not meet the requirement that a serving contain less than 0.5 grams
of trans fat to be labeled zero grams trans fat. However, hydrogena-
tion at higher pressures (200 p.s.i.) yields PHVO that contains as low
as 17% of its total fat as trans fat."17 At this low level, PHVO can be
blended with liquid soybean oil to create oil containing less than 0.5
grams per serving."8 Indeed, inspection of ingredient lists at most
local supermarkets will reveal oils and spreads containing this type
of blend. As a result, artificial trans fats contained in PHVO are
allowed to remain in the food supply even though the IOM has
stated that they are harmful to heart health at any level of consump-
tion."9
However, if the FDA had followed the lead of other govern-
ments that have passed regulations limiting the presence of trans
fats in food, this loophole could have been largely avoided. At the
very least, the blended oils would be allowed to contain even less
PHVO. The Canadian standard, for instance, requires less than 0.2
grams of trans fat per serving in order to state that it contains zero
grams of trans fat on the label,'"6 an amount high enough to be met
by most natural trans fat sources but low enough that the current
blended oils may not pass. CSPI Executive Director Michael Jacob-
son believes that while the current less than 0.5 grams standard has
114. F.J. Eller, Preparation of Spread Oils meeting USFDA Labeling Requirements for
Trans Fatty Acids via Pressure-Controlled Hydrogenation, 53(15)J. AGRIc. & FOOD CHEM-





119. DIETARY REFERENCE INTAKES, supra note 4, at 14.
120. CANADIAN FOOD INSPECTION AGENCY, Information Letter: Labelling of Trans
Fatty Acids, http://www.inspection.gc.ca/english/fssa/labeti/inform/20050914e.
shtml (last visited Feb. 6, 2008).
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brought about positive changes, a less than 0.2 grams standard
would have been preferable. The practical effect of the current
regulation is that, while American consumers can be sold food con-
taining as much as 0.49 grams of artificial trans fat per serving under
the guise of zero grams trans fat, if the Canadian standard were fol-
lowed producers could only include 0.19 grams of trans fat per serv-
ing to make similar claims. Considering the IOM's recommendation
to limit trans fat intake as much as possible, it is almost a truism that
a change in the standard to less than 0.2 grams per serving would be
beneficial. This would accomplish the dual benefits of even lower
PHVO content in foods and lower overall trans fat consumption by
the American public. Given the large expense of health care, par-
ticularly heart surgery and rehabilitation therapy, such a change
would almost certainly result in a positive net economic benefit."
ii. The standard is mandatory, leaving consumers in the dark
Another issue raised by the regulations is that they actually
mandate that the nutrition label for any food containing less than
0.5 grams trans fat per serving report the product's trans fat content
as zero grams.12 This means that a food literally containing zero
grams trans fat is indistinguishable to the average consumer from a
food containing 0.49 grams trans fat per serving. This requirement
puts health-conscious consumers at a considerable disadvantage,
because it prevents them from effectively monitoring the trans fat
content of their food or eliminating it altogether without going to
considerable trouble. Granted, the producer must still list PHVO
on the ingredients list, but that puts the onus on the consumer to
doubt the veracity of the nutrition facts label and then be informed
enough to know that a food product contains artificial trans fat
when its ingredient list includes "partially hydrogenated vegetable
oil." Consequently, the potential confusion engendered by a re-
quirement such as this one, effectively forcing producers to keep
consumers in the dark regarding the actual trans fat content of their
foods and placing the burden on consumers to decipher a mislead-
121. E-mail from MichaelJacobson, supra note 96.
122. See Richard Posner, The Becker-Posner Blog, Comment on the New York Ban on
Trans Fats - Posner (Dec. 17, 2006), http://www.becker-posner-blog.com/
archives/2006/12/the-new-york-ci.hunl (last visited Dec. 28, 2007) (discussing an
analogous economic benefit resulting from the New York ordinance limiting the
presence of trans fat in foods).
123. 21 C.F.R. § 101.9(c)(2)(ii) (2006).
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ing nutrition label, conflicts with the stated purpose behind the gov-
ernment's grant of authority to the FDA to amend its rules "to assist
consumers in maintaining healthy diet practices.""' On the con-
trary, the current situation seems to thwart such consumer attempts
rather than assist them by misleading consumers as to the trans fat
content of their food.
Again, given that the IOM has stated that any amount of trans
fat consumption is harmful to health, 15 and that trans fat has been
shown to be considerably more detrimental to health than saturated
fat in comparable amounts," the FDA's mandate that levels of trans
fat in food up to 0.49 grams per serving be reported as zero grams
may result in considerable negative effects on consumer health rela-
tive to other countries. The average health conscious American
consumer eating three meals with three servings each per day, be-
lieving all along that they have consumed zero grams trans fat, could
actually consume as much as 150% more trans fat daily than a Ca-
nadian consumer eating foods making the same claims but regulated
under the Canadian standard. Consequently, the current rule would
go further toward meeting the goal of the statutory grant of author-
ity if it was amended to require producers to list the actual amount
of trans fat contained in their products to the nearest 0.1 grams if
the content per serving is 0.2 grams or above. Increased consumer
awareness, in turn, might lead to a further reduction in CHD attrib-
utable to trans fat consumption, and a concomitant economic bene-
fit.
iii. The current standard distorts the wholesomeness of high satu-
rated fat foods
Additionally, the current regulations are inherently deceptive to
consumers for another reason-they can make high saturated fat
foods seem more wholesome than they really are. As MichaelJacob-
son has pointed out, the current regulations allow food producers to
claim "zero grams trans fat" on the front of food packaging, even
though the food may contain any amount of saturated fat, which is
generally known to be very detrimental to heart health." The prac-
tical effect of this change is well-illustrated by the Starbucks exam-
ple. Because Starbucks removed all trans fat from its baked goods,
124. 68 Fed. Reg. at 41434.
125. DIETARY REFERENCE INTAKES, supra note 4, at 14.
126. See Hu et al., supra note 66.
127. E-mail from Michael Jacobson, supra note 96.
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it can claim zero grams trans fat even though it switched to high
saturated fat oils that may (because the amount of saturated fat in
them is greater than the amount of trans fat formerly in their reci-
pes) have similar or even more deleterious negative health effects.
The result is that consumers buy a product thinking that it is more
beneficial to their health, when in reality it is potentially just as
harmful or even more harmful than the same product made with
the discarded trans fat-containing recipe. As Jacobson points out,
because the FDA never finalized a rule to end this deception by pre-
venting zero grams trans fat claims on food packaging, such market-
ing continues to the potential detriment of consumers.'
c. The current regulations do not address restaurants
and other food vendors
One of the biggest gaps in the current regulation is its failure to
address retail food service, including street vendors, fast food, deliv-
ery, and fine dining establishments. Many Americans dine out or
have their food delivered to them pre-prepared: the food industry
will make $1.5 billion in sales on the average day in 2007, and four
out of five consumers agree that going out to a restaurant is a better
way to use their leisure time than cooking and cleaning up.' In
fact, restaurants contribute more than one-third of the trans fats in
the American diet. ° The current federal labeling regulations do
nothing to directly address the large percentage of the average
American's daily caloric intake that comes from these sources. As a
result, consumers would have to do a considerable amount of inde-
pendent research to find out how much trans fat they are getting
from foods prepared at the lunch counter. To combat this oversight
in the current federal regulations, state and local governments have
stepped into the regulatory gap left by the FDA and have started
limiting the amount and types of trans fats that retail establishments
may use in preparing their foods.
B. Local Efforts to Limit the Amount of Trans Fat in the Food Supply
In addition to the FDA's failure to address trans fat in the con-
text of food service establishments, state and local regulations have
128. Id.
129. Nat'l Rest. Ass'n, Restaurant Industry Facts, http://www.restaurant.org/
research/ind-glance.cfm (last visited Dec. 28, 2007).
130. New York, N.Y., Dep't of Health & Mental Hygiene, supra note 2, at 2.
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also attempted to fill the gap left by the federal regulation's more
general shortcoming-its failure to directly limit the presence of
trans fats in the food supply. To fill these gaps, many state and city
governments have begun legislating food issues in general, and trans
fats in particular.' 3' These efforts range from initiatives by small
towns urging their local food service establishments to voluntarily
switch from artificial trans fats,'32 to regulations by huge cities such
as New York universally preventing all local food service establish-
ments from using any ingredients containing 0.5 grams or more of
artificial trans fat per serving.
While New York's regulation has been lauded by consumer ac-
tivists such as CSPI's Michael Jacobson,' other locales have either
soft-pedaled regulatory efforts (for instance, Chicago's regulation of
food service establishments at different levels depending on their
yearly income)'35 or used extreme rhetoric broadly comparing trans
fats to food contaminants such as E. coli. Even though such state-
ments may be made to support bans limited to artificial trans fat
use, when they are made without qualification they could potentially
lead to uninformed consumers discontinuing use of products that
list trans fat content that is composed only of natural trans fats that
must be reported under the federal regulation. And nothing is
stopping state or local governments from seizing on such rhetoric
and the inclusion of natural trans fat sources in the federal regula-
tion's definition to fashion a ban on the use of all trans fats by local
food service establishments.
Because so many restaurants are part of national chains that use
pre-prepared components shipped in from large manufacturers,
these local regulations can affect large restaurant and commercial
food supply businesses that operate at the national level by forcing
them to comply broadly so that their franchises may comply locally.
And because of the lack of education on the part of the government,
smaller local businesses faced with impending compliance deadlines
are forced to hastily switch to processed fats that may be only
131. See Lorin, supra note 22.
132. Ban Trans Fats, Project Tiburon: America's First Trans Fat-Free City!!!,
http://www.bantransfats.com/projecttiburon.html (last visited Dec. 28, 2007).
133. New York, N.Y., Dep't of Health & Mental Hygiene, supra note 2.
134. E-mail from MichaelJacobson, supra note 96.
135. See Greg Brown, Proposed Trans Fat Ban Irks Chicago Restaurants, Health Care
News (Oct. 2006), available at http://www.heartland.org/Article.cfm?artId=19744.
136. See Lorin, supra note 22 (noting that Connecticut State Senator Andrew
Roraback has said that trans fats are "as much a contaminant as E. coli.").
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slightly healthier than the trans fats they are meant to replace.'
3 7
Consequently, the local regulations can have regional or national
implications.
Ultimately, the current regulatory situation is one of profound
uncertainty for the businesses that supply our national food system.
Faced with myriad local regulations and the potential for more and
varied regulations daily, food suppliers look to the federal govern-
ment for uniformity and certainty. Finding that the federal gov-
ernment has included natural trans fats in their definition, and fear-
ing that public hysteria will lead local governments to do the same in
directly banning or limiting the presence of trans fats in their local
food supplies, producers and retailers may seek broad preemptive
compliance by taking steps similar to those taken by Starbucks: they
may eliminate all trans fats from their products, even though the
IOM has suggested that such action could have significant negative
consequences."i These natural trans fat sources might then be re-
placed with processed oils high in saturated fats and lacking in nu-
trients that would otherwise prevent vitamin and nutritional defi-
ciencies. The result is a food supply of increasing safety yet decreas-
ing wholesomeness, and a step backward for public health.' 9 The
next section discusses current efforts urging the FDA to take further
action on trans fat regulation to address this problem.
V. THE CSPI PETITION
In an effort to address the gaps in the Food and Drug Admini-
stration's (FDA) labeling regulation and in recognition of the poten-
tial for passage of multifarious local regulations (a fear that has
come to fruition), the Center for Science in the Public Interest
(CSPI) filed a citizen action "Petition for Rulemaking to Revoke the
Authority for Industry to Use Partially Hydrogenated Vegetable Oils
137. See E. Charles Hunt, Executive Vice Pres. of N.Y. State Rest. Ass'n, Testimony
at Public Hearing by City Council Committee on Health (Oct. 30, 2006), available at
http://www.restaurant.org/pressroom/pressrelease.cfm?ID=1332 (quoting the
Chair of the American Heart Association's Nutrition Committee's conclusion that
"consumers should avoid increasing their intake of saturated fat in an effort to
minimize trans fat," and asserting that the New York regulation, phased in over
eighteen months, would force food service establishments to take that step); but see
E-mail from Michael Jacobson, supra note 96 (asserting that restaurants will not
have to take such drastic steps because initial enforcement following the effective
date of the ban will take more than a year).
138. See DIETARY REFERENCE INTAKES, supra note 4, at 14.
139. See Hunt, supra note 137.
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in Foods" on May 18, 2004." While the petition requests rulemak-
ing to bring about several important changes that should be granted
by the FDA, it also explicitly endorses the FDA's current definition
of trans fats.14 1 Consequently, even if the petition is granted (which
is unlikely) it may not go far enough to address the problems with
the current regulatory situation. Moreover, CSPI's desire for
prompt action exposes the time sensitive nature of its requests: be-
cause the FDA has failed to act, CSPI's requests, if granted, may no
longer be fully effective in addressing the problems raised by the
current state of trans fat regulation, as many of the dangers that its
requests were designed to avoid (such as state and local regulation)
have already come to pass.
A. CSPI's Requests
Although CSPI's petition explicitly approves of the FDA's cur-
rent definition of trans fatty acid,'42 it does request that the FDA take
three major actions to limit the use of artificial (but not natural)
trans fats in the food supply:
1. Initiate a rulemaking to:
a. revoke the "generally recognized as safe" (GRAS) status"
of partially hydrogenated oils in foods, "so that they would
be legally classified as food additives" and so that their con-
tinued use would be made illegal absent a regulation "pre-
scribing the conditions under which such additives may be
safely used"; "
140. CSPI, supra note 17, at 9.
141. Id. at 2 n.7.
142. Presumably, this approval is to avoid coming across as unreasonable in their
requests. See id.
143. "Section 201(s) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
§ 321(s), excludes from the legal definition of a food additive an ingredient that 'is
generally recognized, among experts qualified by scientific training and experience
to evaluate its safety, as having been adequately shown . . .to be safe under the
conditions of its intended use.' An ingredient can be classified as 'generally recog-
nized a safe' by a public formal determination by the FDA, a letter from the FDA,
or a self-determination by a food company." Id. at 3 n. 15.
144. Id. at 3-4. "Absent a regulation establishing the conditions whereby a food
additive can be safely used, a food that contains a food additive is adulterated and,
accordingly, cannot legally be introduced into interstate commerce." Id. at 4 n.20
(explaining FFDCA § 409(a)(2), 21 U.S.C. § 348(a)(2)).
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b. "revoke the current 'safe conditions' for those partially hy-
drogenated vegetable oils that the FDA has approved as
food additives"; ' and
c. "prohibit the use of any partially hydrogenated vegetable
oil which is not classified as a food additive because the
FDA sanctioned or approved its use prior to September 6,
1958."'4
2.Announce that the rulemaking will be completed by 2008
given the strong scientific evidence establishing the public health
risks of partially hydrogenated vegetable oil (PHVO), thus allowing
two years to observe the impact of the labeling regulation.'47 Indus-
try should be given two years to adapt before the new regulation
becomes effective.
4 8
3. Immediately (prior to deciding on the merits of the regula-
tory actions requested) develop a program to encourage the food
industry to replace partially hydrogenated vegetable oils with the
most healthful ingredients possible.'
49
4. In the alternative, institute rulemaking or request comments
on setting tolerance levels for trans fats."
B. Analysis of CSPI's Requests
1. A Narrowed Scope Allows CSPI's Tolerance Proposal to Swallow
its Requests for GRAS Removal, "Safe Condition" Revocation,
and Prior Use Prohibition
CSPI's request to remove the GRAS status, "safe conditions" of
use, and prior use exemptions for the various types of artificial trans
fats contained in PHVO seems appropriate because strong scientific
evidence suggests that the FDA should exercise its authority to take
such action.'5' However, CSPI inexplicably qualifies its request for
GRAS removal in a way that essentially allows it to be swallowed by





150. CSPI, supra note 17, at 5. CSPI's petition points out that the Danish gov-
ernment limits trans fats to 2% of the total fat in foods. Id. at 10.
151. See id. at 25 (citing 21 C.F.R. § 170.6(c)). Note that the FDA can initiate
rulemaking sua sponte, rather than waiting to rule on a filed petition. See 21 C.F.R.
§ 10.25 (2006).
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the alternative request for the establishment of partially hydrogen-
ated oil (PHO) ' tolerance levels.
On its face, CSPI's request for GRAS removal seems straight-
forward and well-founded. The FDA distinguishes generally be-
tween substances that are food additives and those that are not.
153
Substances classified as food additives cannot be legally used unless
the FDA has issued a regulation "prescribing the conditions under
which such additive may be safely used."'"M A substance will be
deemed a food additive where: (a) its use or intended use results or
can be reasonably expected to result, directly or indirectly, in its
becoming a component or otherwise affecting the characteristics of
any food, and (b) it is not generally recognized among experts quali-
fied by scientific training and experience to evaluate its safety as
having been adequately shown through scientific procedures to be
safe under the conditions of its intended use.
As the CSPI points out in its petition, PHOs clearly satisfy the
first prong because their intended use directly results in their be-
coming a component in food.'56 Additionally, PHOs satisfy the sec-
ond prong because they are not generally recognized by scientists to
be safe under the conditions of their intended use: the IOM con-
cluded that any amount of trans fat intake increases the risk of
coronary heart disease (CHD), and a federal court of appeals has
held that the absence of a safe level of a substance in food justifies
the FDA's determination that the product is unsafe.5 ' Conse-
quently, the CSPI makes a strong case that artificial trans fats are
food additives. Moreover, it makes an equally strong argument that,
as a food additive, PHO should not be GRAS because the current
scientific evidence should prevent it from meeting the "reasonable
certainty of no harm" standard for approval."'
However, the CSPI limits the scope of its request in a way that
may render it a request for tolerances rather than for an effective
ban. Specifically, the CSPI points out that it intends to exclude from
the proposed rulemaking saturated fats (because of their ubiqui-
tousness and natural origin), natural trans fats (presumably because
of their potential direct and indirect nutritional benefits), and PHO
152. PHO includes PHVO, but also encompasses Menhaden (fish) oil.
153. 21 U.S.C. § 321(s) (2006) (defining "food additive").
154. Id. at § 348(a)(2) (2006).
155. CSPI, supra note 17, at 25-26 (citing 21 U.S.C. § 321(s)).
156. Id. at 26.
157. See id. at 5-27.
158. Id. at 18.
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produced by new methods containing insignificant amounts of artificially
produced trans fat.59 While the first two categories make sense, the
third category essentially requests that the FDA establish an artificial
trans fat tolerance rather than an outright ban. But it seems inter-
nally inconsistent for the CSPI to suggest that some PHOs should be
exempted merely because they contain less trans fat per serving,
given the contention of the Institute of Medicine (1OM) (cited in the
CSPI petition) that the Upper Tolerable Intake Level (UL) of trans
fats be zero. 6° Indeed, this qualification essentially allows CSPI's
alternative request-that the FDA establish tolerance levels for artifi-
cial trans fats-to swallow its main request for a ban on PHO use
through GRAS removal. Consequently, CSPI's main request and its
alternative request essentially reach the same result of tolerance
proposals, though they do so through different means (the former
by virtue of its definition of PHO, the latter explicitly). The main
difference between the two requests, then, is that if the FDA was to
grant the explicit tolerance request, it could forego the formality of
removing the GRAS status for PHO.
It is important to note that the CSPI petition does not address
naturally occurring trans fat (presumably because of the IOM's ob-
servations), nor does it address the de minimis amount of trans fat
occurring in conventionally processed (non-PHO) vegetable oils."'
The exclusion of the trans fats in conventional vegetable oils from
the proposed rulemaking may stem from two rationales: a realiza-
tion that any food produced with such oils will still contain some
amount of trans fats,' 2 and a desire to focus on trans fats from
sources shown to be deleterious to health-the partially hydrogen-
ated variety. Indeed, both rationales would make sense; while the
former makes practical sense, the latter seems to comport with the
impetus for trans fat regulation-the protection of public health.
However, these rationales do not explain CSPI's exclusion of trans
fat from PHVO produced through new processing methods, as
those oils contain the same trans fats from the same source (albeit in
slightly lower amounts) as the trans fat widely recognized as being
harmful to health.
The IOM reports clearly say that the desirable UL for trans fats
is zero, and that it is feasible to plan a diet containing no artificial
159. See id. at 27 n.115.
160. DIETARY REFERENCE INTAKES, supra note 4, at 14.
161. CSPI,supra note 17, at27 n.115.
162. Id.
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trans fats from PHO. The CSPI is not requesting a total ban on all
trans fats, and it seems to acknowledge that such a request would be
impractical.'" Rather, the CSPI requests a tolerance level on the use
of PHO because of the deleterious trans fats that it contains." But
as the IOM reports attest, trans fats from these sources can be
eliminated from foods as a practical and as a scientific matter.'
Consequently, the CSPI petition may not go far enough toward pro-
tecting public health by merely requesting tolerances on the use of
artificial trans fats contained in PHOs.
Regardless of this apparent problem with CSPI's petition, it
goes on to request (on the basis of current scientific evidence and
the FDA's "safe ingredient reexamination" commitment)"67 that the
FDA remove the "safe conditions" of use established for all PHOs
qualified as food additives because the new scientific evidence dem-
onstrates that PHO can no longer be considered safe for use as a
food additive, "unless conditions are established to ensure that the
amount of trans fat is minimal," again suggesting that a tolerance
level would be acceptable." Additionally, the CSPI requests that all
PHOs considered safe because they were in use prior to Septem-
ber 6, 1958, now be considered "unsafe" food adulterants.'6" This
request seems prudent, because while the CSPI acknowledges that
no prior sanction or approval exists for any PHO product, it seeks
to prospectively prevent a company that had a prior use from escap-
ing the requested new rule by seeking retroactive prior use approval
under 21 C.F.R. section 181.1(a).'7 °
Ultimately, while CSPI's request for GRAS removal, "safe con-
dition" revocation, and prior use prohibition seems to be a request
for a ban on its face, closer examination reveals that it is actually a
request for tolerances. In light of the scientific evidence cited by the
CSPI, including its assertion that sufficient substitutes containing no
trans fat exist or will be developed by the time the requested rules
163. DIETARY REFERENCE INTAKES, supra note 4, at 14 (stating that the ideal upper
UL for trans fats is zero); GUIDING PRINCIPLES, supra note 90 (stating that it is feasi-
ble to plan a diet wherein the only trans fats are from non-PHO sources).
164. See CSPI, supra note 17, at 27 n. 115.
165. See id. at 5-27.
166. GUIDING PRINCIPLES, supra note 90.
167. CSPI, supra note 17, at 28 (citing 21 C.F.R. § 170.6(c)).
168. Id. at 28.
169. Id. at 28-29 (citing 21 U.S.C. § 342(a)(2)(A); 21 C.F.R. § 181.1(b)).
170. Id. at 29.
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take effect,'7' CSPI's narrowing of the scope of the PHO to be cov-
ered by its requested regulation seems misguided.
2. The Effective Denial of CSPI's Requests for Announcement and
Education
FDA inaction since the filing of CSPI's petition has shown that
its requests for announcement that rulemaking will be completed by
2008 and for immediate implementation of a far-reaching industry
and consumer education program on trans fats and trans fat substi-
tutes have been effectively denied.
First, the FDA's announcement that it will complete rulemaking
by 2008, as per CSPI's request, has not been forthcoming. On the
contrary, Michael Landa, Deputy Director for Regulatory Affairs for
the Center for Food Safety and Applied Nutrition (CFSAN), has
stated that he can acknowledge only that the petition was filed and
that the FDA is reviewing it.n This would suggest that any rulemak-
ing might take place on the same extended time frame that the cur-
rent labeling regulation endured.
Second, any consumer and industry education by the FDA pur-
suant to CSPI's request for immediate implementation of a far-
reaching, comprehensive program has been minimal. Although some
efforts have been made to passively advise these groups via the inter-
net,"3 the proof is in the pudding: stories such as those involving
Starbucks abound," suggesting that industry, the public, and even
academics remain largely uninformed. Therefore, CSPI's requests on
these fronts seem to have been effectively denied, which does not
bode well for the disposition of the remainder of their petition.
3. CSPI's Prediction of State, Local, and Private Action
As an incentive for the FDA to take prompt action on its peti-
tion, the CSPI warned that should the FDA fail to fill the regulatory
171. CSPI, supra note 17, at 23-25.
172. E-mail from Michael Landa, Dep. Dir. Reg. Affairs, Ctr. for Food Safety &
Applied Nutrition, to Ross Williams, (Mar. 1, 2007, 15:07:19) (on file with author).
173. FDA, Revealing Trans Fats, http://www.pueblo.gsa.gov/cic-text/food/reveal-
fats/reveal-fats.htm (last visited Dec. 28, 2007).
174. See, e.g., Hunt, supra note 137 (quoting the Chair of the American Heart
Association's Nutrition Committee's conclusion that "consumers should avoid in-
creasing their intake of saturated fat in an effort to minimize trans fat," and assert-
ing that the New York regulation, phased in over eighteen months, would force
food service establishments to take that step).
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gaps left by its labeling rule-particularly the allowance for continued
use of trans fats by restaurants and food companies-state and local
governments might legislate to protect consumers further and pri-
vate parties might institute suits.'7" This prediction has proven pro-
phetic: since the CSPI filed its petition, numerous state and local
governments have passed ordinances prohibiting or limiting the use
of trans fats.'7 Moreover, as the CSPI points out, suits that are simi-
lar to those dismissed in the past might be successful in the future
given the increased state of public and industry awareness of the
dangers of trans fats.7 Because state and local governments have
already begun to regulate, engendering reflexive industry actions
such as those discussed herein that could lead to negative effects on
public health and dampen or substantially offset any potential gains
from removing trans fats from the food supply, an effective solution
may need to be more drastic than what the CSPI requests in its peti-
tion.
Ultimately, CSPI's petition was apt for the time and place in
which it was filed. But, as its requests for prompt action reveal, its
petition was time sensitive. Because of the FDA's inactivity while it
considered the merits of CSPI's petition, the problems created by
the current state of federal, state, and local trans fat regulation have
been exacerbated to the point that the FDA may need to exercise its
authority178 to go beyond what the CSPI has recommended if it
hopes to provide an effective remedy for the current problem.
175. "State and local governments are legally free to set standards that are more
protective of public health than the FDA has established in those areas - such as the
safety of food ingredients - for which Congress has not explicitly pre-empted such
action." CSPI, supra note 17, at 30 (citing Hillsborough County, Fla. v. Automated
Med. Laboratories, Inc., 471 U.S. 707 (1985) (holding that a local government can
establish its own regulations beyond those of the FDA absent an explicit statutory
pre-emption clause)).
176. See Nat'l Rest. Ass'n, supra note 15.
177. See CSPI, supra note 17, at 31. (arguing that private parties may in the future
sue restaurants or food companies for continuing to use partially hydrogenated
vegetable oils when healthier alternatives exist, citing for comparison Pelman v.
McDonald, 237 F. Supp. 2d 511, 532 (holding that complaint would state a tort
claim "if McDonald's products are so extraordinarily unhealthy that they are out-
side the reasonable contemplation of the consuming public or that the products are
so extraordinarily unhealthy as to be dangerous in their intended use); BanTrans-
Fats.com v. Kraft Foods N. Am., Inc., CV 032041 (Marin County Super. Ct. Cal. May
2003)).
178. See 21 C.F.R. § 10.25 (2006).
[VOL. 3:39
TROUBLING STATE OF TRANS FAT REGULATION
VI. RECOMMENDATIONS FOR FUTURE ACTION BY THE FDA
The outlook seems bleak for passage of the CSPI petition.
1 7
1
But at this point CSPI's petition may actually not request action
drastic enough to correct the current problems: federal regulatory
inactivity has allowed the window of effectiveness to pass for limited
actions such as those requested by the CSPI-state and local govern-
ments have started regulating trans fats, and various standards and
uncertainty abound among consumers and industry, leading to hasty
preventive measures (such as the elimination of all types of trans fats
and replacement with processed oils) that may be ill-advised. As a
result, more drastic measures may be required if the FDA is to pro-
vide uniformity and certainty to the businesses that supply our na-
tional food system, and thereby prevent the potential negative
health effects that could arise from producers and restaurants over-
reacting to the current lack of uniformity and fears over the poten-
tial tort consequences of continued artificial trans fat use.
While a more libertarian view would advocate allowing the
market to work out the problem on its own, the current state of af-
fairs developed from an unregulated state and demonstrates that
regulatory inaction is inefficient legally, medically, and economi-
cally.' The goal of food regulation should be to ensure that the
food supply is both safe and wholesome. While the current regula-
tory conditions ensure the safety of the food supply by eliminating
179. E-mail from Michael Jacobson, supra note 96 (stating that the current FDA
will not pass CSPI's petition and will have to be taken to court).
180. Legally, while under the current deregulated state some businesses (such as
Kentucky Fried Chicken) will eliminate the use of PHVO and thereby eliminate tort
liability, other businesses that have already been involved in tort litigation may na-
ively seek to avoid or delay eliminating trans fat to avoid the appearance of culpabil-
ity, a move which could potentially lead to further suits with increasing prospects of
success. Additionally, challenges to multiple local ordinances could prove costly
should a national company choose to resist elimination of PHVO. A preemptive
federal regulation limiting or eliminating the use of PHVO could prevent these
problems. Medically, a laissez faire attitude to regulation could result in two ex-
tremes--continued use of PHVO by businesses in some unregulated areas, resulting
in continued elevated CHD levels, or complete elimination (as in the Starbucks
example) resulting in the vitamin and nutrient deficiencies warned of by the IOM,
as well as the loss of the potential benefits of natural trans fat consumption. Eco-
nomically, the savings realized from decreased CHD costs through elimination of
PHVO would be limited by the uneven regulation of those substances from one
locale to another, whereas a uniform preemptive federal ban would maximize those
benefits. See, e.g., Posner, supra note 122 (discussing an analogous economic bene-
fit resulting from the New York ordinance limiting the presence of trans fat in
foods); contra Milloy, supra note 63; Becker, supra note 63.
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harmful artificial trans fats, they may simultaneously reduce the
wholesomeness of the food supply by replacing natural trans fat
sources (and their attendant nutritional benefits) with processed oils
high in saturated fat (and lacking in those attendant nutritional
benefits). Therefore, for the FDA to effectively address the current
situation and ensure a food supply that is both safe and wholesome,
it should exercise its authority to act sua sponte"8 and go beyond
CSPI's requests by:
1. amending the current regulatory definition of trans fatty ac-
ids to exclude natural sources of trans fat (both non-conjugated vac-
cenic acid and conjugated linoleic acid (CLA)) from regulation, re-
quiring labeling of only artificial trans fat content;
2. removing the GRAS status, "safe conditions" for use, and/or
prior approval of all PHVO products containing detectable amounts
of artificial trans fatty acids, effectively banning the use of artificial
trans fats while allowing the continued use of natural trans fats (both
vaccenic acid and CLA);
3. immediately sponsoring a far reaching education program as
per the CSPI petition;
4. following Canada's lead in sponsoring continued research
into the effect of natural trans fat sources on the human body;'"
5. sponsoring further research into the safety of interesterified
fats;' and
6. giving the regulation preemptive effect."M
While the FDA is not required to pass a preemptive regulation
in this area, considerations of public policy'" and federalism strongly
support such action.
181. See 21 C.F.R. § 10.25 (2006).
182. See TRANs FAT TASK FORCE OF HEALTH CANADA, supra note 30, at 41.
183. See Harder, supra note 76 (citing Sundram et al., supra note 76; but quoting
Michael Jacobson, who points out that the study cited "had a 'bizarrely high' pro-
portion of saturated fatty acids," and states that "(i)t looks to me like the palm oil
industry was looking for a way to put a potential competitor in a bad light [by us-
ing] unrealistic conditions.").
184. A full analysis of whether such a regulation would be fully preemptive of
state and local laws is beyond the scope of this paper. However, problems may
arise in that state and local governments are legally free to set standards that are
more protective of public health than the FDA has established in those areas for
which Congress has not explicitly pre-empted such action, and the FFDCA does not
lend preemptive effect to food additive regulations. CSPI, supra note 17, at 30.
This means that a new law that includes an express preemption provision for food
additives may have to be passed to prevent state and local governments from pass-
ing laws to regulate trans fats above and beyond the federal regulations-which is
the key concern arising in this context.
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Our federal system was formed largely in response to the rec-
ognition that a decentralized system impeded interstate commerce.
Similar concerns support passing a preemptive regulation banning
the use of artificial trans fat, as required compliance with multiple
local regulations impedes the business of national food producers
and restaurants and threatens the nutrition of the average Ameri-
can. Consequently, a single preemptive regulation is needed to pro-
vide the uniform standard that the businesses that supply our na-
tional food system require to operate efficiently.
By amending the definition of trans fatty acid, the FDA can end
Starbucks-type problems;" because producers will only have to list
the content of artificial trans fats on their labels, they will be less
likely to eliminate natural sources of trans fat and replace them with
unhealthy processed oils. While this action would result in some
hassle for industry as it readjusts yet again to a new standard, the
total economic benefit of such action could be substantial: rather
than replacing natural trans fat sources that are potentially benefi-
cial to consumer health'87 with processed oils high in harmful satu-
rated fats, the consumers would keep the beneficial substances, re-
sulting in a further reduction in CHD levels. Indeed, the CSPI has
estimated that a 47-fold increase in economic benefits over those
realized under the current FDA labeling regulation could be realized
through a ban on artificial trans fat use."M That estimate translates
into a net economic benefit to the economy of $616 billion to $1.26
trillion over a twenty-year period.'89 Given the high cost of treating
such problems, even a slight reduction could result in a net eco-
nomic benefit. Moreover, the amended definition would better
comport with the purpose of the rule and the authority under which
it was granted, as discussed above. Consequently, the amendment
of the current trans fatty acid definition is crucial to providing for a
safer food supply that continues to be wholesome.
Legally, the FDA's commitment that ingredients previously con-
sidered GRAS must have their GRAS status re-examined in light of
new scientific evidence does not bind the FDA to act." ° However,
185. See id.
186. See id.
187. See supra § III.B.
188. CSPI, supra note 17, at 12.
189. Id.
190. See Lars Noah & Richard A. Merrill, Starting from Scratch?: Reinventing the
Food Additive Approval Process, 78 B.U.L. Rev. 329, 359 (1998) ("To revise or repeal
an existing GRAS regulation, the FDA would need to follow only notice-and-
comment rulemaking procedures.").
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given the strong scientific evidence that artificial trans fats are dan-
gerous, the FDA's refusal to remove the GRAS status of these sub-
stances would seem disingenuous and effectively render the FDA's
re-examination commitment meaningless. Such refusal would also
represent bad public policy by allowing industry to continue to use a
substance known to be harmful to consumer health."' In that event,
suits against the FDA and individual companies to force such action
are likely and would be appropriate."
A private party has individual rights to compel the FDA to insti-
tute a rulemaking where a significant factual predicate of a prior
decision on the subject (either to promulgate or not to promulgate
specific rules) has been removed.'93 Such a right has been found
where new evidence came out eliminating any question as to
whether raw milk consumption is dangerous following regulation of
raw milk sales in interstate commerce that was partially stayed so
that the Secretary could determine, through a public hearing,
whether the consumption of raw milk is safe.' Here, shortly after
the final rule was passed in July of 2003, the IOM responded to the
FDA's request for information by issuing the December 2003 re-
port ' implying that it would be feasible to exclude PHVO from the
diet, recognizing that natural trans fats should be left in the diet,
and referring back to its conclusion from the July 2003 report that
trans fats are more deleterious than saturated fats.'" In the situation
presented here, the labeling requirement could be viewed as a stay
pending IOM results that might warrant a more decisive action. Just
as evidence came forward in the raw milk case warranting further
rulemaking to ban the sale of raw milk,"97 evidence came to light
here following the implementation of the labeling rule that warrants
many of the recommendations herein. A suit to compel rulemaking
may prove fruitful here on the rationale that this new evidence con-
stitutes the removal of a factual predicate of the original labeling
rule.
Were GRAS removal, "safe use" revocation, and prior use pro-
hibition granted, they would effectively constitute a ban on artificial
191. See supra § III.B.
192. See E-mail from Michael Jacobson, supra note 96 (wherein Dr. Jacobson states
that the CSPI will probably have to take the FDA to court to have their requests
met).
193. Pub. Citizen v. Heckler, 653 F. Supp. 1,229, 1,241 (D.D.C. 1986).
194. See id.
195. See GUIDING PRINCIPLES, supra note 90, at 100.
196. See DIETARY REFERENCE INTAKES, supra note 4, at 14.
197. See Heckler, 653 F. Supp. at 1,232.
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trans fat use. Upon such action, artificial trans fats would be con-
sidered new food additives, and as such would have to be shown to
pose a "reasonable certainty of no harm" before being approved for
use.' The burden for showing "a reasonable certainty of no harm"
rests on the applicant'": in this case, a company seeking approval of
a PHO would have to show that it did not pose an increased risk of
heart disease. There is virtually no likelihood that a company could
do this in the face of the current scientific evidence to the contrary,
and as a result any GRAS removal would essentially function as a
ban on artificial trans fat use. Additionally, if the current evidence
linking artificial trans fat consumption to cancer is strengthened,
approval following GRAS removal might be prevented by the De-
laney Clause.'
The key to making trans fat regulation effective in the long
term will be education and continued research."°1 Even if artificial
trans fats are banned, optimum benefits to public health and the
economy will not be realized unless producers and consumers un-
derstand the difference between harmful and beneficial trans fats,
and are aware of the healthiest substitutes available. In this vein,
continued research should be conducted to confirm or refute the
preliminary evidence that natural trans fats are beneficial to health,
and further research should be conducted on the healthfulness of
interesterified fats so that their use may be appropriately curtailed
should the preliminary studies prove reliable.
The most important aspect of these recommendations to insure
the amelioration of the short-term issues raised in this article is the
suggestion that the regulations be made preemptive. Only through
lending these changes preemptive effect can the FDA hope to cure
the uncertainty and misguided action that industry's attempts to
achieve broad compliance with multiple local regulations have en-
gendered. While enforcement of these standards could be left up to
local authorities, the definition and limitations upon the use of trans
fats should be controlled by one uniform, preemptive federal stan-
dard. Aside from the economic and regulatory benefits that a pre-
emptive standard would provide, regulation would also confer a
crucial benefit on the public in that it would obviate, to some extent,
198. See CSPI, supra note 17, at 22.
199. Id.
200. 21 U.S.C. § 348(c)(3)(A) (2006).
201. Both research and education are addressed by the Canadian Trans Fat Task
Force in their recommendations. TRANS FAT TASK FORCE OF HEALTH CANADA, supra
note 30, at 41.
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the need for consumers to be minutely informed to follow the best
dietary practices. As Richard Posner has observed, we live in a
world of nearly unlimited information, and the individual's ability to
absorb and apply all of that information is finite."2 The bottom line
is that a single standard will remove the guesswork from producing
and consuming foods that are both safe and wholesome, at least as
far as trans fat content is concerned, by consolidating the informa-
tion assimilation process.
Another issue regarding current trans fat regulation involves its
effect on tort litigation. While some commentators have voiced
concern that a trans fat ban would start a "lawsuit bonanza, " " in
reality the FDA's adoption of these or similar recommendations may
actually head off such litigation to a large extent."° Under the cur-
rent regulatory system, some producers and restaurants (including
McDonald's) have either put off their promises to switch from trans
fats or have neglected to do so altogether."5 Given the early rulings
in tort claims for obesity caused by fast food products, the prefer-
ence of some companies to ignore the "pink elephant" of scientific
evidence that trans fats are harmful may actually lead to more law-
suits down the road.0 6 On the other hand, a preemptive federal ban
on the use of artificial trans fats that explicitly acknowledges their
harmfulness would prompt the holdouts to make the switch away
from artificial trans fats promptly, as their continued use would no
longer be suspect. The faster that this change takes place, the less
likelihood that a "lawsuit bonanza" may occur. Think of it as a taxi
meter: the more artificial trans fat containing foods that consumers
eat during the period that some fast food companies continue to
include PHOs in their food despite scientific evidence and public
awareness that they are harmful, the more money in terms of poten-
tial damages and settlement amounts that accrues against those
companies on behalf of consumers that fall ill or die as a result of
CHD attributable to trans fat consumption. Considering the Danish
Nutrition Council's finding that, gram for gram, consumption of
trans fatty acids instead of saturated fats results in a ten fold higher
202. See Posner, supra note 122.
203. Milloy, supra note 63.
204. See CSPI, supra note 17, at 31.
205. Associated Press, McDonald's Revisits Fat in Fries: New Test Shows Fries Contain
a Third More Tram Fat Than Thought (Feb. 8, 2006), available at
http://www.cbsnews.com/stories/2006/02/08/health/man1299086.shtml.
206. See CSPI, supra note 17, at 30-31 (arguing that private parties may in the
future sue restaurants or food companies for continuing to use partially hydrogen-
ated vegetable oils when healthier alternatives exist).
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risk increment for the development of heart disease,27 such accrual
could be considerable and the likelihood for claim success signifi-
cant. The FDA and industry can stop the meter on these claims now
by banning artificial trans fats preemptively and doing so as soon as
possible. Or they can let the meter continue to run into the hun-
dreds of millions or even billions of dollars.
VII. CONCLUSION
On balance, only time will tell if industry and consumer prac-
tice regarding trans fats has changed to the extent that amending
the regulatory system will not yield positive changes. The ball can-
not be advanced when an agency buries its head in the sand, as the
current state of affairs attests. On the contrary, where an agency
abdicates its obligation to provide uniform federal regulations to a
national industry, chaos can ensue as state and local governments
attempt to regulate the industry via multiple local ordinances. Con-
sumers may have already decided that all trans fats are harmful, and
producers may have determined that it is better to simply remove all
trans fats from their recipes, even though those actions may not only
be misguided, but harmful to public health. Nevertheless, the ex-
perience to date with trans fat regulation suggests that a laissez-faire
approach does not achieve optimum outcomes. Should the current
situation continue unchanged, ten years from now the Institute of
Medicine's concern regarding nutritional deficiencies from the
elimination of natural trans fat sources' may come to fruition, a
new round of increasing coronary heart disease may develop from
increased use of interesterified fats and processed oils to replace
trans fats, and settlement and damages from trans fat tort suits may
rival those previously realized in tobacco litigation. The better
course-legally, medically, and economically-may be to make the
appropriate changes now, cross our fingers, and hope that it is not
too late to ensure that, in terms of trans fat content, our food supply
will be both safe and wholesome.
207. STEEN STENDER & JoRN DYERBERG, DANISH NUTRITION COUNCIL, THE
INFLUENCE OF TRANS FATrY ACIDS ON HEALTH, 4th ed., at 9 (2003), available at
http://www.meraadet.dk/gfx/uploads/Rapporter-pdf/Trans%20fatty%20acids-4.t
h%20ed._UK www.pdf.
208. See DIETARY REFERENCE INTAKES, supra note 4, at 14.
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